Pfizer Corporation (PFE)

As talk of a possible fiscal stimulus continues, the dollar descended to two-year lows and rates eased slightly this morning on investor hopes of new cash being sprinkled into the economy from Washington, D.C. This stimulus talk, which goes in and out like a radio broadcast you can sometimes hear...

While the pandemic is raging for the second time this year, pharmaceutical giants are giving the world hope of ending the COVID-19 nightmare. On Monday, Moderna Inc (NASDAQ: MRNA) said it will apply for U.S. and European emergency authorization of its vaccine candidate as late-stage study results...

Now that November has come to a close, the holidays and a much-needed break seem that much closer. Before fully diving into the final 23 trading days of 2020, however, take a look at where U.S. equities ended the month. Despite the major indices, excluding the Nasdaq-100, closing Monday in the red...

After the whipsaw year we’ve had, many investors would probably be just fine with a dull December. There are signs they might get it, with many of the rough spots receding. The election was almost a month ago, earnings season is practically over, and, perhaps best of all, vaccines appear on...

Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) were the first to deliver good news regarding the efficiency of their coronavirus vaccine candidate. Moderna Inc (NASDAQ: MRNA) had its turn last week delivering even better news with U.S. stocks hitting a new record. This Monday,...

Investors this morning seem to be continuing to weigh competing forces.  On the one hand, surging coronavirus cases and related state restrictions to curb the virus’s spread seem to be weighing on sentiment, exacerbated by news that California has banned nonessential work and gatherings...

After the year we’ve had on Wall Street, some of us might welcome a little dullness. Maybe that’s starting to emerge as the holidays approach, though virus shutdown fears continue to weigh this morning and could upend things at any time—as we saw with yesterday’s late sell-...

Russell 2000 futures have noticeably outperformed their cohorts in the other major equity indices, with the small-caps climbing about 16% this month. Although the contract has not yet pushed past its Pfizer Inc. (NYSE: PFE) vaccine announcement peak on Nov. 9, it moved above a resistance level near...

There are two unique things about this rally in bitcoin. The first is that it’s happening without much retail excitement. The second is that it’s happening almost entirely on its own – unaccompanied by stocks, gold, or other cryptocurrencies. That’s particularly interesting...

Vaccine makers are batting 1000, to borrow a baseball term. So far they’ve gone two for two in terms of positive results, and Wall Street is rounding the bases again early Monday.  Moderna Inc (NASDAQ: MRNA) became the latest company to announce an effective vaccine, kicking off...

Earlier this week, meaningful progress on the pandemic front was announced after Pfizer Inc. (NYSE: PFE) and partner BioNTech SE (NASDAQ: BNTX) said their Covid-19 vaccine was highly effective in combating the virus. This compelling news rewarded value investors that held to their beliefs, stuck...

The vaccine news is continuing to give the stock market a shot in the arm. News earlier in the week that a vaccine from Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) demonstrated more than 90% effectiveness against COVID-19 has helped propel stocks higher as...

We’re calling this article, “November Outlook.” Maybe a better name is “Nov. 3 Outlook,” because it’s kind of hard to look past that date. Next Tuesday’s election determines far more than who gets the White House key on Jan. 20. From a market perspective,...

After stumbling to start the week, it looks like Wall Street is trying to get back on its feet this morning. Major indices—which recovered some of their losses in the last hour yesterday—made up more ground in pre-market trading despite fading stimulus hopes and more shutdowns due to...